Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sunho Biologics,Inc. ( (HK:2898) ) has provided an announcement.
Sunho Biologics, Inc. announced its unaudited consolidated interim results for the first half of 2025, reporting a loss of RMB 38,199,000, which is slightly higher than the loss reported in the same period in 2024. Despite the loss, the company saw a significant increase in cash and cash equivalents, rising from RMB 79 million at the end of 2024 to RMB 171 million by mid-2025, indicating improved liquidity and financial stability.
More about Sunho Biologics,Inc.
Sunho Biologics, Inc. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. The company focuses on research and development, providing innovative biological solutions and products.
Average Trading Volume: 10,734
Technical Sentiment Signal: Buy
Learn more about 2898 stock on TipRanks’ Stock Analysis page.